Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study. (Q51192901)

1 April 2018

title

Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study. (English)

1 reference

1 April 2018

0 references

3

1 reference

1 April 2018

author name string

Sarah Mostardt

1

1 reference

1 April 2018

Nikola Hanhoff

2

1 reference

1 April 2018

Armin Goetzenich

4

1 reference

1 April 2018

Knud Schewe

5

1 reference

1 April 2018

Eva Wolf

6

1 reference

1 April 2018

Christoph Mayr

7

1 reference

1 April 2018

Hans Jaeger

8

1 reference

1 April 2018

Holger Pfaff

9

1 reference

1 April 2018

Stephan Dupke

10

1 reference

1 April 2018

Anja Neumann

11

1 reference

1 April 2018

publication date

19 September 2012

1 reference

1 April 2018

The European Journal of Health Economics

published in

1 reference

1 April 2018

volume

14

1 reference

1 April 2018

issue

5

1 reference

1 April 2018

page(s)

799-808

1 reference

1 April 2018

https://scigraph.springernature.com/pub.10.1007/s10198-012-0425-4

exact match

0 references

cites work

Cost effectiveness of highly active antiretroviral therapy in HIV-infected patients. Swiss HIV Cohort Study.

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Costs and adherence to antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Costs of intermittent versus continuous antiretroviral therapy in patients with controlled HIV infection: a substudy of the ANRS 106 Window Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Analysis of costs and cost-effectiveness in multinational trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Sex differences in antiretroviral therapy-associated intolerance and adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Estimating the national cost of treating people with HIV disease: patient, payer, and provider data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

Factors associated with HIV-infected women's delay in seeking medical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

[Burden of disease and level of patient's medical care in substitution treatment for opiates].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10198-012-0425-4

[Appraisal of resource use in the German health-care system from the perspective of the statutory health insurance]

21 January 2018

1 reference

12 December 2020

The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

1 reference

12 December 2020

[Empirical standard costs for health economic evaluation in Germany -- a proposal by the working group methods in health economic evaluation]

1 reference

12 December 2020

[Deficits in socioeconomic and psychosocial support of HIV-positive women]

1 reference

12 December 2020

Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.

1 reference

12 December 2020

[Economic aspects of ambulatory and inpatient treatment of HIV positive patients]

1 reference

12 December 2020

[The cost of an HIV patient. Lack of funds for optimal treatment?]

1 reference

12 December 2020

10.1007/S10198-012-0425-4

Identifiers

DOI

1 reference

1 April 2018

PubMed ID

22990377

1 reference

1 April 2018